EBIT: Income before interest and taxes.
Purple Biotech Ltd. Sponsored ADR (PPBT) had EBIT of $-2.25M for the most recently reported fiscal quarter, ending 2026-03-31.
| Income Statement Financials | |
-- |
|
$-0.09M |
|
-- |
|
-- |
|
$2.25M |
|
$-2.25M |
|
$2.16M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
$-0.09M |
|
|
EBIT |
$-2.25M |
$-2.19M |
|
0.93M |
|
0.93M |
|
$-0.09 |
|
$-0.09 |
|
| Balance Sheet Financials | |
$6.78M |
|
$0.12M |
|
$7.64M |
|
$14.42M |
|
$4.59M |
|
-- |
|
$0.16M |
|
$4.75M |
|
$9.66M |
|
$2.30M |
|
$9.66M |
|
-- |
|
| Cash Flow Statement Financials | |
$-3.12M |
|
$0.04M |
|
$-0.06M |
|
$8.72M |
|
$5.57M |
|
$-3.15M |
|
$0.09M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.48 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-3.12M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-0.92% |
|
-3.86% |
|
-0.62% |
|
-0.92% |
|
-- |
|
$-3.35 |
|
$-3.35 |
|